Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trial

Nicola C. Day; Subramanya Kumar; Gerard Criner; Mark Dransfield; David M. G. Halpin; MeiLan K. Han; C. Elaine Jones; Morrys C. Kaisermann; Sally Kilbride; Peter Lange; David A. Lomas; Neil Martin; Fernando J. Martinez; Dave Singh; Robert Wise; David A. Lipson

doi:10.1186/s12931-020-01398-w

Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trial

Nicola C. Day, Subramanya Kumar, Gerard Criner, Mark Dransfield, David M. G. Halpin, MeiLan K. Han, C. Elaine Jones, Morrys C. Kaisermann, Sally Kilbride, Peter Lange, David A. Lomas, Neil Martin, Fernando J. Martinez, Dave Singh, Robert Wise, David A. Lipson

Afdeling for Epidemiologi

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

10 Citationer (Scopus)

76 Downloads (Pure)

Originalsprog	Engelsk
Tidsskrift	Respiratory research
Vol/bind	21
Antal sider	12
ISSN	1465-9921
DOI	https://doi.org/10.1186/s12931-020-01398-w
Status	Udgivet - 2020

Adgang til dokumentet

10.1186/s12931-020-01398-wLicens: CC BY

Single-inhaler triple therapy fluticasone furoateForlagets udgivne version, 800 KBLicens: CC BY

Citationsformater

Day, N. C., Kumar, S., Criner, G., Dransfield, M., Halpin, D. M. G., Han, M. K., Jones, C. E., Kaisermann, M. C., Kilbride, S., Lange, P., Lomas, D. A., Martin, N., Martinez, F. J., Singh, D., Wise, R., & Lipson, D. A. (2020). Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trial. Respiratory research, 21. https://doi.org/10.1186/s12931-020-01398-w

Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD : results on cardiovascular safety from the IMPACT trial. / Day, Nicola C.; Kumar, Subramanya; Criner, Gerard; Dransfield, Mark; Halpin, David M. G.; Han, MeiLan K.; Jones, C. Elaine; Kaisermann, Morrys C.; Kilbride, Sally; Lange, Peter; Lomas, David A.; Martin, Neil; Martinez, Fernando J.; Singh, Dave; Wise, Robert; Lipson, David A.

I: Respiratory research, Bind 21, 2020.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Day, NC, Kumar, S, Criner, G, Dransfield, M, Halpin, DMG, Han, MK, Jones, CE, Kaisermann, MC, Kilbride, S, Lange, P, Lomas, DA, Martin, N, Martinez, FJ, Singh, D, Wise, R & Lipson, DA 2020, 'Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trial', Respiratory research, bind 21. https://doi.org/10.1186/s12931-020-01398-w

Day, Nicola C. ; Kumar, Subramanya ; Criner, Gerard ; Dransfield, Mark ; Halpin, David M. G. ; Han, MeiLan K. ; Jones, C. Elaine ; Kaisermann, Morrys C. ; Kilbride, Sally ; Lange, Peter ; Lomas, David A. ; Martin, Neil ; Martinez, Fernando J. ; Singh, Dave ; Wise, Robert ; Lipson, David A. / Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD : results on cardiovascular safety from the IMPACT trial. I: Respiratory research. 2020 ; Bind 21.

@article{50a4bc21b36249e9a44371ea901bad9e,

title = "Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trial",

keywords = "COPD, Triple therapy, LAMA/LABA, ICS/LABA, Cardiovascular safety",

author = "Day, {Nicola C.} and Subramanya Kumar and Gerard Criner and Mark Dransfield and Halpin, {David M. G.} and Han, {MeiLan K.} and Jones, {C. Elaine} and Kaisermann, {Morrys C.} and Sally Kilbride and Peter Lange and Lomas, {David A.} and Neil Martin and Martinez, {Fernando J.} and Dave Singh and Robert Wise and Lipson, {David A.}",

year = "2020",

doi = "10.1186/s12931-020-01398-w",

language = "English",

volume = "21",

journal = "Respiratory Research (Print)",

issn = "1465-9921",

publisher = "BioMed Central Ltd.",

}

TY - JOUR

T1 - Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD

T2 - results on cardiovascular safety from the IMPACT trial

AU - Day, Nicola C.

AU - Kumar, Subramanya

AU - Criner, Gerard

AU - Dransfield, Mark

AU - Halpin, David M. G.

AU - Han, MeiLan K.

AU - Jones, C. Elaine

AU - Kaisermann, Morrys C.

AU - Kilbride, Sally

AU - Lange, Peter

AU - Lomas, David A.

AU - Martin, Neil

AU - Martinez, Fernando J.

AU - Singh, Dave

AU - Wise, Robert

AU - Lipson, David A.

PY - 2020

Y1 - 2020

KW - COPD

KW - Triple therapy

KW - LAMA/LABA

KW - ICS/LABA

KW - Cardiovascular safety

U2 - 10.1186/s12931-020-01398-w

DO - 10.1186/s12931-020-01398-w

M3 - Journal article

C2 - 32503599

VL - 21

JO - Respiratory Research (Print)

JF - Respiratory Research (Print)

SN - 1465-9921

ER -